{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T01:09:47Z","timestamp":1785287387889,"version":"3.55.0"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T00:00:00Z","timestamp":1659139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["602102"],"award-info":[{"award-number":["602102"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.nbd.2022.105835","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T11:44:34Z","timestamp":1659527074000},"page":"105835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy"],"prefix":"10.1016","volume":"173","author":[{"given":"Alessia","family":"Salamone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Terrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Di Sapia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Balosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ravizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Craparotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Mannarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Raimondi","family":"Cominesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Rizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Pauletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Porcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till S.","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Aronica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"During","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Abrahams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Vezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2022.105835_bb0005","author":"Akkerman"},{"key":"10.1016\/j.nbd.2022.105835_bb0010","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.2174\/1570159X19666210826125341","article-title":"Elucidating the potential side effects of current anti-seizure drugs for epilepsy","volume":"19","author":"Aky\u00fcz","year":"2021","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.nbd.2022.105835_bb0015","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/glia.22312","article-title":"Astrocyte immune response in epilepsy","volume":"60","author":"Aronica","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2022.105835_bb0020","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.wneu.2016.12.074","article-title":"Prevalence and incidence of drug-resistant mesial temporal lobe epilepsy in the United States","volume":"99","author":"Asadi-Pooya","year":"2017","journal-title":"World Neurosurg."},{"key":"10.1016\/j.nbd.2022.105835_bb0025","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.nbd.2016.03.007","article-title":"Current understanding and neurobiology of epileptic encephalopathies","volume":"92","author":"Auvin","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105835_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J. R. Stat. Soc."},{"key":"10.1016\/j.nbd.2022.105835_bb0035","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/epi.14557","article-title":"Progress report on new antiepileptic drugs: a summary of the fourteenth Eilat conference on new antiepileptic drugs and devices (EILAT XIV). I. Drugs in preclinical and early clinical development","volume":"59","author":"Bialer","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/glia.20318","article-title":"Increased seizure duration and slowed potassium kinetics in mice lacking aquaporin-4 water channels","volume":"53","author":"Binder","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2022.105835_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(01)02277-7","article-title":"On the turnover of brain cholesterol in patients with Alzheimer\u2019s disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells","volume":"314","author":"Bogdanovic","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2022.105835_bb0050","doi-asserted-by":"crossref","first-page":"34674","DOI":"10.1074\/jbc.M402324200","article-title":"Differential expression of cholesterol hydroxylases in Alzheimer\u2019s disease","volume":"279","author":"Brown","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105835_bb0055","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1126\/science.aan4074","article-title":"Dentate gyrus mossy cells control spontaneous convulsive seizures and spatial memory","volume":"359","author":"Bui","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.nbd.2022.105835_bb0060","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a015826","article-title":"The kinetochore","volume":"6","author":"Cheeseman","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.nbd.2022.105835_bb0065","doi-asserted-by":"crossref","first-page":"37033","DOI":"10.1038\/srep37033","article-title":"Neuroprotection mediated through GluN2C-containing N-methyl-D-aspartate (NMDA) receptors following ischemia","volume":"6","author":"Chung","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2022.105835_bb0070","doi-asserted-by":"crossref","first-page":"17540","DOI":"10.1073\/pnas.1311967110","article-title":"Astrocyte control of synaptic NMDA receptors contributes to the progressive development of temporal lobe epilepsy","volume":"110","author":"Clasadonte","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2022.105835_bb0075","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022434","article-title":"Role of astrocytes in epilepsy","volume":"5","author":"Coulter","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.nbd.2022.105835_bb0080","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.molbrainres.2004.12.005","article-title":"Differential expression of NMDA receptor subunits and splice variants among the CA1, CA3 and dentate gyrus of the adult rat","volume":"135","author":"Coultrap","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2022.105835_bb0085","doi-asserted-by":"crossref","first-page":"10588","DOI":"10.1523\/JNEUROSCI.2323-09.2009","article-title":"Astrocytic dysfunction in epileptogenesis: consequence of altered potassium and glutamate homeostasis?","volume":"29","author":"David","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105835_bb0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2022.105835_bb0095","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.nbd.2022.105835_bb0100","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/epi.16956","article-title":"Microglia proliferation plays distinct roles in acquired epilepsy depending on disease stages","volume":"62","author":"Di Nunzio","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105468","article-title":"CXCL1-CXCR1\/2 signaling is induced in human temporal lobe epilepsy and contributes to seizures in a murine model of acquired epilepsy","volume":"158","author":"Di Sapia","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105835_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106825","article-title":"RNA sequencing analysis of cortex and hippocampus in a kainic acid rat model of temporal lobe epilepsy to identify mechanisms and therapeutic targets related to inflammation, immunity and cognition","volume":"87","author":"Dong","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.nbd.2022.105835_bb0115","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0140-6736(93)90754-5","article-title":"Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain","volume":"341","author":"During","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2022.105835_bb0120","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cellsig.2013.11.011","article-title":"The toll-like receptor 2\/1 (TLR2\/1) complex initiates human platelet activation via the src\/Syk\/LAT\/PLC\u03b32 signalling cascade","volume":"26","author":"F\u00e4lker","year":"2014","journal-title":"Cell. Signal."},{"key":"10.1016\/j.nbd.2022.105835_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainresrev.2010.09.002","article-title":"Role of glia in epilepsy-associated neuropathology, neuroinflammation and neurogenesis","volume":"66","author":"Foresti","year":"2011","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.nbd.2022.105835_bb0130","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"2008"},{"key":"10.1016\/j.nbd.2022.105835_bb0135","first-page":"3130","article-title":"N-3 Docosapentaenoic acid-derived protectin D1 promotes resolution of neuroinflammation and arrests epileptogenesis","volume":"141","author":"Frigerio","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2022.105835_bb0140","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0006-8993(98)01202-5","article-title":"Mossy cells in the mouse dentate gyrus: identification in the dorsal hilus and their distribution along the dorsoventral axis","volume":"816","author":"Fujise","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2022.105835_bb0145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.yebeh.2011.07.024","article-title":"The NMDA receptor complex as a therapeutic target in epilepsy: a review","volume":"22","author":"Ghasemi","year":"2011","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.nbd.2022.105835_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/00207454.2014.940941","article-title":"NMDARs in neurological diseases: a potential therapeutic target","volume":"125","author":"Gonzalez","year":"2015","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105835_bb0155","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/epi.13688","article-title":"Toll-like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE-induced epilepsy in mice","volume":"58","author":"Gross","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0160","article-title":"Efficacy, safety and tolerability of soticlestat (TAK-935\/OV935) as adjunctive therapy in pediatric patients with Dravet syndrome and Lennox Gasteau syndrome (ELEKTRA)","volume":"851","author":"Hahn","year":"2020","journal-title":"Am. Epilepsy Soc. Abstr."},{"key":"10.1016\/j.nbd.2022.105835_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106646","article-title":"A phase 1b\/2a study of soticlestat as adjunctive therapy in participants with developmental and\/or epileptic encephalopathies","volume":"174","author":"Halford","year":"2021","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.nbd.2022.105835_bb0170","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ni1204","article-title":"Enhanced toll-like receptor responses in the absence of signaling adaptor DAP12","volume":"6","author":"Hamerman","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.nbd.2022.105835_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105346","article-title":"Disturbances of brain cholesterol metabolism: a new excitotoxic process associated with status epilepticus","volume":"154","author":"Hanin","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105835_bb0180","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1111\/epi.17062","article-title":"Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, reduces seizures and premature death in Dravet syndrome mice","volume":"62","author":"Hawkins","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.brainres.2012.08.018","article-title":"Bi-lateral changes to hippocampal cholesterol levels during epileptogenesis and in chronic epilepsy following focal-onset status epilepticus in mice","volume":"1480","author":"Heverin","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2022.105835_bb0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.brainresbull.2017.02.011","article-title":"The role of aquaporin-4 in synaptic plasticity, memory and disease","volume":"136","author":"Hubbard","year":"2018","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2022.105835_bb0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ilar.46.2.148","article-title":"Environmental enrichment for laboratory rodents","volume":"46","author":"Hutchinson","year":"2005","journal-title":"ILAR J."},{"key":"10.1016\/j.nbd.2022.105835_bb0200","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1074\/jbc.272.1.63","article-title":"Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI","volume":"272","author":"Ichinohe","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105835_bb0205","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.nbd.2013.03.006","article-title":"Receptor for advanced glycation endproducts is upregulated in temporal lobe epilepsy and contributes to experimental seizures","volume":"58","author":"Iori","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105835_bb0210","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2016.12.007","article-title":"Blockade of the IL-1R1\/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy","volume":"99","author":"Iori","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105835_bb0215","first-page":"D498","article-title":"The reactome pathway knowledgebase","volume":"48","author":"Jassal","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2022.105835_bb0220","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2022.105835_bb0225","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/0976-500X.72351","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"1","author":"Kilkenny","year":"2010","journal-title":"J. Pharmacol. Pharmacother."},{"key":"10.1016\/j.nbd.2022.105835_bb0230","doi-asserted-by":"crossref","first-page":"12228","DOI":"10.1021\/acs.jmedchem.1c00864","article-title":"Discovery of Soticlestat, a potent and selective inhibitor for cholesterol 24-hydroxylase (CH24H)","volume":"64","author":"Koike","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.nbd.2022.105835_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.nbd.2012.03.032","article-title":"Increased glial glutamate transporter EAAT2 expression reduces epileptogenic processes following pilocarpine-induced status epilepticus","volume":"47","author":"Kong","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105835_bb0240","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/glia.20455","article-title":"Downregulation of Kir4.1 inward rectifying potassium channel subunits by RNAi impairs potassium transfer and glutamate uptake by cultured cortical astrocytes","volume":"55","author":"Kucheryavykh","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2022.105835_bb0245","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0250","doi-asserted-by":"crossref","first-page":"22980","DOI":"10.1074\/jbc.M303415200","article-title":"Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover","volume":"278","author":"Lund","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2022.105835_bb0255","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0404.2006.00683.x","article-title":"Cholesterol metabolism in the brain: importance of 24S-hydroxylation","volume":"185","author":"L\u00fctjohann","year":"2006","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1016\/j.nbd.2022.105835_bb0260","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mce.2019.01.016","article-title":"Oxysterols and nuclear receptors","volume":"484","author":"Ma","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.nbd.2022.105835_bb0265","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nm.2127","article-title":"Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures","volume":"16","author":"Maroso","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.nbd.2022.105835_bb0270","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022798","article-title":"Common mechanisms underlying epileptogenesis and the comorbidities of epilepsy","volume":"6","author":"Mazarati","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.nbd.2022.105835_bb0275","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.brainres.2008.03.061","article-title":"Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice","volume":"1213","author":"Mouri","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2022.105835_bb0280","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.neuroscience.2004.08.053","article-title":"Aquaporin-4 in the central nervous system: cellular and subcellular distribution and coexpression with KIR4.1","volume":"129","author":"Nagelhus","year":"2004","journal-title":"Neuroscience"},{"issue":"Suppl. 8","key":"10.1016\/j.nbd.2022.105835_bb0285","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1528-1167.2007.01358.x","article-title":"What is animal experimentation telling us about new drug treatments of status epilepticus?","volume":"48","author":"Nehlig","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0290","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.1038\/s41598-020-74036-6","article-title":"Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice","volume":"10","author":"Nishi","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2022.105835_bb0295","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/epi.17232","article-title":"Anticonvulsive properties of soticlestat, a novel cholesterol 24-hydroxylase inhibitor","volume":"63","author":"Nishi","year":"2022","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0300","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.steroids.2015.02.003","article-title":"Induction of oxiapoptophagy on 158N murine oligodendrocytes treated by 7-ketocholesterol-, 7\u03b2-hydroxycholesterol-, or 24(S)-hydroxycholesterol: protective effects of \u03b1-tocopherol and docosahexaenoic acid (DHA; C22:6 n-3)","volume":"99","author":"Nury","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.nbd.2022.105835_bb0305","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1750-3639.2003.tb00026.x","article-title":"Increase in cholesterol and cholesterol oxidation products, and role of cholesterol oxidation products in kainate-induced neuronal injury","volume":"13","author":"Ong","year":"2003","journal-title":"Brain Pathol."},{"key":"10.1016\/j.nbd.2022.105835_bb0310","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12035-010-8099-3","article-title":"Changes in brain cholesterol metabolome after excitotoxicity","volume":"41","author":"Ong","year":"2010","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.nbd.2022.105835_bb0315","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nn.2535","article-title":"Selective induction of astrocytic gliosis generates deficits in neuronal inhibition","volume":"13","author":"Ortinski","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2022.105835_bb0320","doi-asserted-by":"crossref","first-page":"7535","DOI":"10.1080\/03610918.2016.1241410","article-title":"Comparing the performance of normality tests with ROC analysis and confidence intervals","volume":"46","author":"Patr\u00edcio","year":"2017","journal-title":"Commun. Stat. Simul. Comput."},{"key":"10.1016\/j.nbd.2022.105835_bb0325","doi-asserted-by":"crossref","first-page":"17290","DOI":"10.1523\/JNEUROSCI.2619-13.2013","article-title":"The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors","volume":"33","author":"Paul","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105835_bb0330","doi-asserted-by":"crossref","DOI":"10.1093\/brain\/awz130","article-title":"Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy","volume":"142","author":"Pauletti","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2022.105835_bb0335","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022822","article-title":"Epileptogenesis","volume":"5","author":"Pitkanen","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.nbd.2022.105835_bb0340","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.nbd.2016.05.013","article-title":"1400W, a highly selective inducible nitric oxide synthase inhibitor is a potential disease modifier in the rat kainate model of temporal lobe epilepsy","volume":"93","author":"Puttachary","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2022.105835_bb0345","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/cne.21605","article-title":"Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain","volume":"507","author":"Ramirez","year":"2008","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2022.105835_bb0350","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1523\/JNEUROSCI.1574-14.2015","article-title":"Reactive astrogliosis causes the development of spontaneous seizures","volume":"35","author":"Robel","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2022.105835_bb0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.freeradbiomed.2013.02.002","article-title":"Mitochondrial involvement and oxidative stress in temporal lobe epilepsy","volume":"62","author":"Rowley","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.nbd.2022.105835_bb0360","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/nrn.2016.87","article-title":"The enigmatic mossy cell of the dentate gyrus","volume":"17","author":"Scharfman","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2022.105835_bb0365","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0370","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/0024-3205(79)90321-7","article-title":"Distribution and persistence of kainic acid in brain","volume":"24","author":"Scherer-Singler","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.nbd.2022.105835_bb0375","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/brain\/awy071","article-title":"KEAP1 inhibition is neuroprotective and suppresses the development of epilepsy","volume":"141","author":"Shekh-Ahmad","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2022.105835_bb0380","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/emboj.2012.31","article-title":"Cholesterol loss during glutamate-mediated excitotoxicity","volume":"31","author":"Sodero","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2022.105835_bb0385","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1073858414568122","article-title":"24(S)-hydroxycholesterol as a modulator of neuronal signaling and survival","volume":"22","author":"Sun","year":"2016","journal-title":"Neuroscientist"},{"key":"10.1016\/j.nbd.2022.105835_bb0390","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/epi.13950","article-title":"Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet","volume":"59","author":"Terrone","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107742","article-title":"Inflammation and reactive oxygen species as disease modifiers in epilepsy","volume":"167","author":"Terrone","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2022.105835_bb0400","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1471-4159.2010.06661.x","article-title":"Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer\u2019s disease","volume":"113","author":"Tian","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2022.105835_bb0405","doi-asserted-by":"crossref","first-page":"4.1-4.19","DOI":"10.1146\/annurev-pharmtox-010814-124607","article-title":"Candidate drug targets for prevention or modification of epilepsy","volume":"55","author":"Varvel","year":"2015","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2022.105835_bb0410","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3171\/jns.2002.97.5.1125","article-title":"Extravascular collagen in the human epileptic brain: a potential substrate for aberrant cell migration in cases of temporal lobe epilepsy","volume":"97","author":"Veznedaroglu","year":"2002","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.nbd.2022.105835_bb0415","article-title":"Immunity and inflammation in epilepsy","volume":"6","author":"Vezzani","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.nbd.2022.105835_bb0420","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41582-019-0217-x","article-title":"Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy","volume":"15","author":"Vezzani","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.nbd.2022.105835_bb0425","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1037\/0735-7044.106.3.457","article-title":"Loss of hippocampal CA1 pyramidal neurons correlates with memory impairment in rats with ischemic or neurotoxin lesions","volume":"106","author":"Volpe","year":"1992","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2022.105835_bb0430","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/j.1528-1167.2011.03086.x","article-title":"Stereologic estimation of hippocampal GluR2\/3- and calretinin-immunoreactive hilar neurons (presumptive mossy cells) in two mouse models of temporal lobe epilepsy","volume":"52","author":"Volz","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.nbd.2022.105835_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4141\/A03-123","article-title":"The use of mixed models in the analysis of animal experiments with repeated measures data","volume":"84","author":"Wang","year":"2004","journal-title":"Can. J. Anim. Sci."},{"key":"10.1016\/j.nbd.2022.105835_bb0440","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuropharm.2018.12.028","article-title":"Preferential enhancement of GluN2B-containing native NMDA receptors by the endogenous modulator 24S-hydroxycholesterol in hippocampal neurons","volume":"148","author":"Wei","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2022.105835_bb0445","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1194\/jlr.M300164-JLR200","article-title":"Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration","volume":"44","author":"Xie","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.nbd.2022.105835_bb0450","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.nbd.2009.12.020","article-title":"Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of tuberous sclerosis complex","volume":"37","author":"Zeng","year":"2010","journal-title":"Neurobiol. Dis."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122002273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996122002273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:35:15Z","timestamp":1760852115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996122002273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":90,"alternative-id":["S0969996122002273"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105835","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cholesterol 24-hydroxylase is a novel pharmacological target for anti-ictogenic and disease modification effects in epilepsy","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2022.105835","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Takeda Pharmaceutical Company Limited and The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"105835"}}